Aggregated
42% success rate- Bullish
- 0
- Hold
- 9
- Bearish
- 0
Goldman Sachs
A Goldman Sachs analyst with 39 tracked ratings covering 30 distinct tickers has a 41.9% success rate on the captured sample, primarily issuing 9 hold ratings in the second source category and 8 bullish ratings in the first.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| PCVX | 2025-04-01 | buy | $100.00 | Aggregated |
| PCVXVAXCYTE INC | 2025-04-01 | unknown | $100.00 | Aggregated |
| ERAS | 2025-03-21 | buy | $3.00 | Aggregated |
| MCRB | 2025-03-14 | sell | $0.75 | Aggregated |
| ALKSALKERMES PLC | 2025-02-14 | unknown | $32.00 | Aggregated |
| PCVX | 2024-12-20 | buy | $135.00 | Aggregated |
| SNDXSYNDAX PHARMACEUTICALS INC | 2024-11-07 | unknown | $33.00 | Aggregated |
| ERAS | 2024-10-25 | buy | $3.50 | Aggregated |
| ERAS | 2024-08-14 | buy | $3.00 | Aggregated |
| ERASERASCA INC | 2024-08-14 | unknown | $3.00 | Aggregated |
| RPRX | 2024-08-14 | buy | $51.00 | Aggregated |
| RPRXROYALTY PHARMA PLC - ORDINARY SHARES - CLASS A | 2024-08-14 | unknown | $51.00 | Aggregated |
| AMLX | 2024-07-12 | hold | $4.00 | Aggregated |
| ERAS | 2024-05-28 | buy | $4.00 | Aggregated |
| RVNCREVANCE THERAPEUTICS INC | 2024-05-13 | hold | $8.00 | Aggregated |
| OGN | 2024-05-06 | hold | $20.00 | Aggregated |
| OGNORGANON & CO. | 2024-05-06 | hold | $20.00 | Aggregated |
| OGN | 2024-05-03 | hold | $20.00 | Aggregated |
| LLYLILLY(ELI) & CO | 2024-04-11 | hold | $723.00 | Aggregated |
| AMLXAMYLYX PHARMACEUTICALS INC | 2024-03-11 | hold | $4.00 | Aggregated |
| SDGR | 2024-03-01 | hold | $26.00 | Aggregated |
| BNTXBIONTECH SE - ADR | 2024-02-28 | hold | $100.00 | Aggregated |
| OGN | 2024-02-20 | hold | $18.00 | Aggregated |
| RPRX | 2024-02-20 | buy | $50.00 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 2024-01-25 | unknown | $153.00 | Aggregated |
| ABBVABBVIE INC | 2023-12-11 | unknown | $173.00 | Aggregated |
| MCRB | 2023-11-03 | sell | $1.25 | Aggregated |
| OGN | 2023-11-03 | hold | $16.00 | Aggregated |
| BMYBRISTOL-MYERS SQUIBB CO. | 2023-10-30 | unknown | $69.00 | Aggregated |
| INVA | 2023-03-03 | hold | $13.00 | Aggregated |
| RVMDREVOLUTION MEDICINES INC | 2023-03-01 | hold | $23.00 | Aggregated |
| KYMRKYMERA THERAPEUTICS INC | 2022-12-16 | unknown | $52.00 | Aggregated |
| PFEPFIZER INC. | 2022-12-13 | unknown | $60.00 | Aggregated |
| TRDAENTRADA THERAPEUTICS INC | 2022-11-08 | hold | $18.00 | Aggregated |
| INVAINNOVIVA INC | 2022-07-20 | hold | $16.00 | Aggregated |
| EXAIEXSCIENTIA PLC - ADR | 2022-05-24 | unknown | $20.00 | Aggregated |
| NKTRNEKTAR THERAPEUTICS | 2022-04-18 | unknown | $3.00 | Aggregated |
| JNJJOHNSON & JOHNSON | 2022-04-12 | hold | $181.00 | Aggregated |
| TNGXTANGO THERAPEUTICS INC | 2021-09-07 | unknown | $17.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| PCVX | 2 | 2025-04-01 | Aggregated |
| PCVXVAXCYTE INC | 1 | 2025-04-01 | Aggregated |
| ERAS | 4 | 2025-03-21 | Aggregated |
| MCRB | 2 | 2025-03-14 | Aggregated |
| ALKSALKERMES PLC | 1 | 2025-02-14 | Aggregated |
| SNDXSYNDAX PHARMACEUTICALS INC | 1 | 2024-11-07 | Aggregated |
| ERASERASCA INC | 1 | 2024-08-14 | Aggregated |
| RPRX | 2 | 2024-08-14 | Aggregated |
| RPRXROYALTY PHARMA PLC - ORDINARY SHARES - CLASS A | 1 | 2024-08-14 | Aggregated |
| AMLX | 1 | 2024-07-12 | Aggregated |
| RVNCREVANCE THERAPEUTICS INC | 1 | 2024-05-13 | Aggregated |
| OGN | 4 | 2024-05-06 | Aggregated |
| OGNORGANON & CO. | 1 | 2024-05-06 | Aggregated |
| LLYLILLY(ELI) & CO | 1 | 2024-04-11 | Aggregated |
| AMLXAMYLYX PHARMACEUTICALS INC | 1 | 2024-03-11 | Aggregated |
| SDGR | 1 | 2024-03-01 | Aggregated |
| BNTXBIONTECH SE - ADR | 1 | 2024-02-28 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 1 | 2024-01-25 | Aggregated |
| ABBVABBVIE INC | 1 | 2023-12-11 | Aggregated |
| BMYBRISTOL-MYERS SQUIBB CO. | 1 | 2023-10-30 | Aggregated |
| INVA | 1 | 2023-03-03 | Aggregated |
| RVMDREVOLUTION MEDICINES INC | 1 | 2023-03-01 | Aggregated |
| KYMRKYMERA THERAPEUTICS INC | 1 | 2022-12-16 | Aggregated |
| PFEPFIZER INC. | 1 | 2022-12-13 | Aggregated |
| TRDAENTRADA THERAPEUTICS INC | 1 | 2022-11-08 | Aggregated |
| INVAINNOVIVA INC | 1 | 2022-07-20 | Aggregated |
| EXAIEXSCIENTIA PLC - ADR | 1 | 2022-05-24 | Aggregated |
| NKTRNEKTAR THERAPEUTICS | 1 | 2022-04-18 | Aggregated |
| JNJJOHNSON & JOHNSON | 1 | 2022-04-12 | Aggregated |
| TNGXTANGO THERAPEUTICS INC | 1 | 2021-09-07 | Aggregated |